NEW Our free Dividend Tracker is live — see what your stocks pay you
Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.
Start Free »

NOVT | NASDAQ

$143.58 $1.39 | 0.98%
SIGNAL:Signal available — unlock to view |2026-08-19 |F&G 36 |RSI 50.4

Company Overview:

Market Cap: $5.89B
Trailing PE: 92x
FWD PE *: 36x
Payout Ratio (TTM): —
52-Week Range: $98.27 - $176.38

* Forward PE is based on street estimates.

10 Year NOVT Performance Metrics:

Total Return (with DRIP): 738% (23.69% CAGR)
Total Return (no DRIP): 738% (23.69% CAGR)
Share Price: 738% (23.69% CAGR)
Yield on Cost (with DRIP): —
Total Invested: $10,000
Total Value (with DRIP): $83,818
Total Return $ (with DRIP): $73,818
NOVT Total Return
1M 3M 6M YTD 1Y 3Y 5Y 10Y
NOVT Price Chart
1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)

NOVT Fundamentals: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

NOVT - Revenue
NOVT Revenue CAGR:1Y: 10.27%2Y: 6.16%5Y: 9.67%10Y: 10.52%
NOVT - Earnings Per Share (EPS)
NOVT EPS CAGR:1Y: 150.00%2Y: -11.15%5Y: -1.89%10Y: 7.92%
NOVT - Net Income
🔓 See the full chart40% off right now · 7-day free trial
NOVT Net Income CAGR:1Y: 178.87%2Y: -4.51%5Y: 1.46%10Y: 9.92%
NOVT - EBITDA
🔓 See the full chart40% off right now · 7-day free trial
NOVT EBITDA CAGR:1Y: 115.22%2Y: 17.51%5Y: 17.89%10Y: 13.68%
NOVT - Free Cash Flow
🔓 See the full chart40% off right now · 7-day free trial
NOVT Free Cash Flow CAGR:1Y: 391.84%2Y: 26.07%5Y: 22.11%10Y: 16.44%
NOVT - Free Cash Flow / Share
🔓 See the full chart40% off right now · 7-day free trial
NOVT Free Cash Flow / Share CAGR:1Y: 341.75%2Y: 19.35%5Y: 19.08%10Y: 14.77%
NOVT - Operating Income
🔓 See the full chart40% off right now · 7-day free trial
NOVT Operating Income CAGR:1Y: 11.20%2Y: 9.01%5Y: 8.18%10Y: 14.93%
NOVT - Gross Profit
🔓 See the full chart40% off right now · 7-day free trial
NOVT Gross Profit CAGR:1Y: 21.07%2Y: 7.99%5Y: 11.93%10Y: 11.29%
NOVT - Shares Outstanding
🔓 See the full chart40% off right now · 7-day free trial
NOVT Shares Outstanding CAGR:1Y: 14.10%2Y: 6.80%5Y: 2.85%10Y: 1.67%
NOVT - Share Buybacks
🔓 See the full chart40% off right now · 7-day free trial
NOVT Share Buybacks CAGR:1Y: 16,455.63%2Y: 0.00%5Y: 0.00%10Y: 30.03%
NOVT - Stock-Based Comp
🔓 See the full chart40% off right now · 7-day free trial
NOVT Stock-Based Comp CAGR:1Y: 31.18%2Y: 25.64%5Y: 14.33%10Y: 25.01%
NOVT - Expenses
🔓 See the full chart40% off right now · 7-day free trial
NOVT Expenses CAGR:1Y: 120.40%2Y: 22.98%5Y: -0.29%10Y: 9.75%
NOVT - Revenue vs Net Income
🔓 See the full chart40% off right now · 7-day free trial
NOVT - EPS vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
NOVT - EPS vs PE Ratio
🔓 See the full chart40% off right now · 7-day free trial
NOVT - FCF vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
NOVT - FCF vs Stock Based Comp
🔓 See the full chart40% off right now · 7-day free trial
NOVT - Cash & Debt
🔓 See the full chart40% off right now · 7-day free trial
NOVT - Revenue by Segment
🔓 See the full chart40% off right now · 7-day free trial
NOVT Revenue CAGR:1Y: 10.27%2Y: 6.16%5Y: 9.67%10Y: 10.52%
NOVT - Revenue by Region
🔓 See the full chart40% off right now · 7-day free trial
NOVT Revenue CAGR:1Y: 10.27%2Y: 6.16%5Y: 9.67%10Y: 10.52%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

NOVT - REVENUE: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
NOVT Actual Revenue CAGR:1Y: 10.27%2Y: 6.16%5Y: 9.67%10Y: 10.52%
NOVT - EPS: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
NOVT Actual EPS CAGR:1Y: 150.00%2Y: -11.15%5Y: -1.89%10Y: 7.92%
NOVT - NET INCOME: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
NOVT Actual Net Income CAGR:1Y: 178.87%2Y: -4.51%5Y: 1.46%10Y: 9.92%
NOVT - EBITDA: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
NOVT Actual EBITDA CAGR:1Y: 115.22%2Y: 17.51%5Y: 17.89%10Y: 13.68%

Ratios, Profit Margins & Return on Capital:

NOVT - Net Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
NOVT Net Profit Margin CAGR:1Y: 152.41%2Y: -10.02%5Y: -7.47%10Y: -0.53%
NOVT - Gross Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
NOVT Gross Profit Margin CAGR:1Y: 9.80%2Y: 1.73%5Y: 2.06%10Y: 0.69%
NOVT - Price to Earnings
🔓 See the full chart40% off right now · 7-day free trial
NOVT Price to Earnings CAGR:1Y: -51.85%2Y: 10.24%5Y: 4.62%10Y: 16.95%
NOVT - Price To Sales Ratio
🔓 See the full chart40% off right now · 7-day free trial
NOVT Price To Sales Ratio CAGR:1Y: 28.43%2Y: 0.19%5Y: -2.97%10Y: 16.49%
NOVT - Return on Capital Employed
🔓 See the full chart40% off right now · 7-day free trial
NOVT Return on Capital Employed CAGR:1Y: -53.87%2Y: -32.04%5Y: -19.06%10Y: -7.89%
NOVT - Return on Invested Capital
🔓 See the full chart40% off right now · 7-day free trial
NOVT Return on Invested Capital CAGR:1Y: -53.87%2Y: -33.13%5Y: -19.61%10Y: -6.30%

Compare stocks side-by-side

Projected Future Returns & Dividends for NOVT

Based on past 10-year performance, here are NOVT growth metrics:

Share price CAGR of +23.53%
Dividend CAGR of +0%

Using NOVT CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

NOVT (DRIP)NOVT - No DRIP
Current Price$143.58$143.58
Start Shares69.6569.65
Start Value$10,000$10,000
  
After 10 years:
Final Share Count69.6569.65
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$143.58$143.58
Total Dividends$0$0
Final Value$10,000$10,000

Estimated Future Value + Dividends - NOVT

NOTE: Above numbers are our estimate based on NOVT's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)

Company Info

Novanta Inc. (NOVT) had its IPO on 1999-03-24, and is traded on NASDAQ stock exchange.

Operating globally, Novanta Inc. and its affiliated companies specialize in the development, production, and distribution of advanced photonics, vision, and precision motion components and sub-assemblies. These highly engineered solutions are supplied to Original Equipment Manufacturers (OEMs) across the medical and industrial sectors. Within its Photonics division, Novanta provides a suite of laser-driven technologies. These encompass systems for laser scanning, beam manipulation, and various laser types such as CO2, solid-state, ultrafast, and optical light engines. Their applications span critical areas like industrial manufacturing, precision measurement (metrology), advanced imaging in healthcare and biological research, DNA sequencing, and specialized medical laser treatments. The Vision segment delivers an array of medical-grade innovations. This portfolio comprises instruments like medical insufflators, pumps, and their associated consumables, alongside comprehensive visualization tools. It also features wireless communication systems, video recording devices, and integration platforms designed for operating theaters. Further offerings include optical data acquisition, machine vision systems, radio frequency identification (RFID) solutions, thermal recording devices, spectrometry equipment, and integrated touchscreen displays. Furthermore, the Precision Motion division specializes in supplying components such as optical and inductive encoders, high-precision motors, servo drives, and complete motion control systems. This segment also delivers integrated stepper motors, sophisticated robotic end-effectors, air bearings, and air bearing spindles. Novanta distributes its extensive product lines through various channels, including its dedicated direct sales team, value-added resellers, distribution partners, and system integrators. These offerings are available under well-known brand names such as Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, NDSsi, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, Celera Motion, MicroE, Zettlex, Applimotion, Ingenia, and Westwind. Founded in 1968, the company operated as GSI Group, Inc. until its rebranding to Novanta Inc. in May 2016. Its corporate headquarters are located in Bedford, Massachusetts.

NOVT website: https://www.novanta.com


Get Full Access to All Reports with DRIPCalc PRO

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)
Loading signals…

DCF Model — NOVT

Value from:
Pay up to today
—
vs current price $143.58
—
Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
YearFCFImplied price
Sensitivity — fair value: growth ↓ × target return →